Todralazine hydrochloride
CAS No. 3778-76-5
Todralazine hydrochloride ( Ecarazine hydrochloride )
Catalog No. M26848 CAS No. 3778-76-5
Todralazine hydrochloride is a β2AR blocker and has antioxidant and free radical scavenging activities. Todralazine hydrochloride can be used in anti-hypertensive research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 35 | Get Quote |
|
50MG | 72 | Get Quote |
|
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTodralazine hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionTodralazine hydrochloride is a β2AR blocker and has antioxidant and free radical scavenging activities. Todralazine hydrochloride can be used in anti-hypertensive research.
-
DescriptionTodralazine hydrochloride is a β2AR blocker and has antioxidant and free radical scavenging activities. Todralazine hydrochloride can be used in anti-hypertensive research.
-
SynonymsEcarazine hydrochloride
-
PathwayAngiogenesis
-
TargetAdrenergic Receptor
-
RecptorBTK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number3778-76-5
-
Formula Weight268.7
-
Molecular FormulaC11H13ClN4O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.CCOC(=O)NNc1nncc2ccccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Xuejun Zhang, et al. Discovery and Evaluation of Pyrazolo[3,4- d]pyridazinone as a Potent and Orally Active Irreversible BTK Inhibitor. ACS Med Chem Lett. 2019 Dec 11;11(10):1863-1868.
molnova catalog
related products
-
LUN42518 HCl 47142-...
LUN42518 HClis an analogue of phentolamine.Phentolamine is a nonselective alpha-adrenergic antagonist.
-
Bambuterol
A long acting beta-adrenoceptor agonist (LABA) used in the treatment of asthma.
-
BRL 37344 sodium
BRL 37344 is a potent and selective β3 adrenoceptor agonist with Ki of 287 nM; has weaker binding affinity for β1 and β2 receptors with Ki of 1750 and 1120 nM, respectively.